Why is the Minhai 13 price cheaper than the Watson 13 price?

Cost, technology.

1. Minhai 13 products are very cheap pneumonia.

13-valent conjugate vaccine with very low cost. And Watson.

13 The raw materials are very precious, and it is very expensive to extract vaccines.

2. Minhai 13 product uses dual-vector pneumonia 13-valent conjugate vaccine, which is very simple and easy. Watson 13 is technically difficult and the steps are very cumbersome. As a result, Minhai 13 is cheaper.

The fact that Minhai 13 is cheaper than Watson 13 may be due to several factors:

1.Raw materials and production processes are different: Watson 13-valent vaccine uses more precious raw materials, and the cost of extracting the vaccine is higher, so it will be higher.

The Minhai 13-valent vaccine uses a lower-cost dual-vector pneumonia 13-valent conjugate vaccine, and the production process is relatively simple.

2.Different technology and R&D costs: Watson 13-valent vaccine is independently developed by Walvax Biologics, and the technology is relatively mature, while Minhai 13-valent vaccine is the first self-developed 13-valent pneumococcal vaccine in China, which is relatively higher in R&D costs, resulting in higher research.

3.Different market strategies: Minhai 13-valent vaccine has been on the market for a short time and has not been widely accepted, so it may not have been included in the medical insurance list in some regions, which may also affect it**.

The Watson 13-valent vaccine has been on the market for a long time and may have been included in the medical insurance catalogue in some regions, so it has affected its ** to a certain extent.

To sum up, the reason why Minhai 13 is cheaper than Watson 13 may be due to the influence of many factors such as raw materials, production process, technology and R&D costs, as well as market strategy.

Minhai's dual vector is far superior to Watson's single vector in terms of technology and immune effect. The process is more complex and avoids epitope inhibition from a single vector. As for the ** are all independent pricing of enterprises, whether they set prices with conscience or chase profits, you have your own conclusions.

Quite simply, because the times are evolving, and technology is advancing. In this era, there are many examples of latecomers taking the top, in the same type of product market as a latecomer, if there is no technological breakthrough, no cost upgrade, can not bring better choices to the people, then how can it be better than others

Watson 13 price raw materials are so expensive, is musk and bezoar added? These two can't be hit in the child's body!

Isn't it okay for conscientious companies to do something good to make vaccines more accessible and accessible to children in remote mountainous areas? Being slaughtered makes you so cool?

When my child was injected, I happened to read the Watson manual, compared with my child's Minhai, the non-inferior conditions are much harsher than Watson, and the raw materials are so "expensive", and the Watson manual itself says that the basic immunization after the 6b type can not achieve protection, and the material is too much?

Because the imported 13-valent vaccine has been very difficult before, Watson is only a little cheaper than the import, and many families may not be able to afford it, probably to let more children get 13-valent!

This depends on whether the company is reluctant to give up, like two identical things, one **high and one **low.